Why Bath & Body Works stock is back in focus after Q2 earnings

Bath & Body Works (BBWI) is drawing renewed attention after second quarter results on 26 August 2026 came in ahead of expectations, supported by tariff refunds, cost controls and a return to digital sales growth.

Management used the update to lift the full year adjusted earnings outlook and increase free cash flow expectations. At the same time, the company pointed to ongoing pressure in store traffic and specific product categories.

At a share price of $19.22, Bath & Body Works has seen mixed momentum, with a 1 day share price return of 3.06% after the Q2 beat and guidance update, but a year to date share price return down 7.33% and a 1 year total shareholder return down 31.34%. Recent product launches such as the Reserve Collection and the raised full year earnings guidance have sharpened the focus on whether recent weakness in total shareholder returns reflects lingering concerns about store traffic and category pressure, or a shift in how investors are weighing the company’s profitability and cash flow outlook.

Scan how Bath & Body Works compares to other retailers with solid cash generation and balance sheets by reviewing our hand picked list of solid balance sheet and fundamentals (51 results).

After a 3.06% one day move and a 31.34% total shareholder return decline over the past year, Bath & Body Works now raises a simple valuation puzzle. Is most of the upside already priced in, or still ahead?

Most Popular Narrative: 48.1% Undervalued

Bath & Body Works closed at $19.22, while the most followed narrative from user mdebaugh14 anchors fair value at $37.05 per share using a discounted cash flow approach. That gap has turned valuation into the key talking point after the latest earnings update.

Most investors look at BBWI and see a mall candle retailer. That framing undersells it significantly. Bath & Body Works is better understood as a repeat-purchase fragrance subscription business operating through a physical and digital retail network. Its customers do not buy candles once; they return four, six, eight times a year to replenish their preferred scents. The company retains a 44.3% gross margin on $7.3 billion in revenue, generating $886 million in operating cash flow economics that are exceptional for any consumer business and essentially impossible to replicate without the brand loyalty Bath & Body Works has built over three decades.

Want to see what supports a fair value almost double the current price? This narrative leans heavily on cash flow strength, premium margins and repeat purchasing economics. Curious which cash flow assumptions and profit durability views push the valuation to $37.05? The full narrative lays out every step in the DCF path so you can judge the inputs for yourself.

Result: Fair Value of $37.05 (UNDERVALUED)

However, Bath & Body Works still faces pressure if store traffic weakens further or if fragrance and body care demand softens, which could challenge the cash flow narrative.

Next Steps

With mixed signals around Bath & Body Works in this article, it makes sense to move quickly, review the numbers yourself, and weigh both sides using the 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Bath & Body Works?

If you only focus on Bath & Body Works, you could miss other compelling setups that match your risk, income and value preferences across the market.

• Capture potential mispricings by scanning our hand picked 45 high quality undervalued stocks that combine strong fundamentals with more attractive entry points.
• Lock in income focused opportunities by reviewing a curated group of reliable payers through the 12 dividend fortresses.
• Sleep easier at night by concentrating on financially resilient companies sourced from the 74 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.